![]() |
||||||||||
![]() |
||||||||||
Jeffrey D. Wager, MD
President and Chief Executive Officer Georg Nebgen, PhD, Director John Costantino, Director Hironori Hozoji, Director Philippe Chambon, MD, PhD, Director Heng-Tong Choo, Director Gary Shearman, PhD, Director Board of DirectorsHeng-Tong Choo, Director Heng-Tong, who joined Bio*One Capital in 2003, is focused on biotechnology and medical device investments in eastern US companies. He is actively involved with Bio*One portfolio companies, including A-Bio Pharma, CombinatoRx and Vanda Pharmaceuticals. Prior to joining Bio*One Capital, Heng-Tong was Director of Chicago Center, Singapore Economic Development Board, where he worked with health care companies such as Eli Lilly, Procter & Gamble Pharmaceutical and GE Healthcare to develop their operations in Singapore. Heng-Tong earned his masters in biotechnology from Columbia University and his masters in engineering from Imperial College, London.
![]() |
||||||||||
![]() |
||||||||||